Literature DB >> 9611908

Technology assessment of the Dutch Lung Transplantation Program.

P J van Enckevort1, E M TenVergert, G J Bonsel, A Geertsma, W van der Bij, W J de Boer, M A Koopmanschap, M J Al, F F Rutten.   

Abstract

The costs, effects, and cost-effectiveness of the Dutch Lung Transplantation program were assessed. The results show that lung transplantation is a very costly intervention that improves survival and quality of life. Costs per life-year and per QALY gained were, respectively, US $90,000 and US $71,000.

Mesh：

Year:  1998        PMID： 9611908     DOI： 10.1017/s0266462300012307

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN： 0266-4623            Impact factor:   2.188


  5 in total

1.  A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients.

Authors:  C J Clancy; S M Bartsch; M H Nguyen; D R Stuckey; R K Shields; B Y Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-07       Impact factor: 3.267

2.  Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients.

Authors:  P J van Enckevort; J H Zwaveling; J T Bottema; J K Maring; I J Klompmaker; M J Slooff; E M TenVergert
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Technology and outcomes assessment in lung transplantation.

Authors:  Roger D Yusen
Journal:  Proc Am Thorac Soc       Date:  2009-01-15

Review 4.  The "health benefit basket" in the Netherlands.

Authors:  Elly A Stolk; Frans F H Rutten
Journal:  Eur J Health Econ       Date:  2005-12

5.  Incorporating ex-vivo lung perfusion into the UK adult lung transplant service: an economic evaluation and decision analytic model.

Authors:  N McMeekin; A E Chrysos; L Vale; A J Fisher
Journal:  BMC Health Serv Res       Date:  2019-05-22       Impact factor: 2.655
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.